|

Rapamycin Clinical Trials

3 actively recruiting trials across 2 locations

▼ -1 trial since June 2026

Also known as: Rapamune, sirolimus, Sirolimus, RAPA

Pipeline

Phase 1: 2Phase 2/3: 1

Top Sponsors

  • Umoja Biopharma1
  • Nanjing IASO Biotechnology Co., Ltd.1
  • AgelessRx1

Indications

  • Cancer2
  • Geroscience1
  • Longevity1
  • GLP - 11
  • Lymphoma, Large B-Cell, Diffuse (DLBCL)1

Other1 trial

UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
Phase 1

Duarte, California1 trial

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

City of Hope

Phase 1

Chicago, Illinois1 trial

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

AgelessRx

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.